Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Global Trading Strategies Closes on Macro Strategy Disappointments

Global Trading Strategies, the Sydney-based fund founded by a group of three former Goldman Sachs JBWere Pty. traders, closed after its macro investment strategy failed reported Bloomberg Thursday.

The Rise and Fall of Global Trading Strategies

Global Trading Strategies was founded by Brett Allender, Andrew Peden and Karl Mayer in 2005. It officially stopped trading July 31 after having negative returns for over a year. It had peaked at a portfolio value of $1.2 billion in 2008. Chief Operating Officer Murray Chatfield explained to Bloomberg Businessweek, “The principals decided that the current environment wasn’t conducive to their trading style and they thought it better to hand money back to investors.” He said, “A lot of our investors didn’t want us to do it, but we thought it was the correct thing to do,” he said. “At some point we’d make a decision on how and when to re-enter the market.”

Global Trading Isn’t Alone – The Hedge Fund Market is ‘Quite Tough’

According to Damien Hatfield, director at Triple A Partners Australia, “It’s actually quite tough” for some hedge funds at the moment. “If markets trend up and markets trend down, they’re good environments for hedge funds,” he said. “But when they go up and down sharply they’re not good because a lot of these guys are trying to find a trend and stay with it.” In fairness, hedge funds fell 3.2% in September. Funds using macro strategies specifically lost 2.4% in September and were down 3.3% for the year as of October 1.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!